Madrigal Pharmaceuticals to Participate in the 2026 Cantor Global Healthcare Conference

manilatimes.net · 2026-09-02

CONSHOHOCKEN, Pa., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that the company will participate in the 2026 Cantor Global Healthcare Conference on Thursday, Sept. 10, 2026 at 1:00 P.M. EDT.

TickrTrends take: Madrigal Pharmaceuticals' participation in the 2026 Cantor Global Healthcare Conference provides an opportunity for investors to assess management commentary and pipeline updates that could inform the company's valuation as TickrTrends completes its analysis. The conference setting typically allows for detailed discussions on clinical progress, commercial strategy, and financial outlook, all of which are relevant inputs for establishing a comprehensive valuation in the Healthcare sector. Investors awaiting TickrTrends' full valuation should monitor any announcements regarding product development milestones or market positioning that emerge from the company's conference participation.

Read the full story at manilatimes.net →